HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

491.458

-11.940-2.37%

Number of Gainers:6

Number of Losers:24

Number of Flat:3

PE:- -

High:505.901

Open:503.516

Low:489.953

Close:503.398

Volume:43.00M

Turnover:1.57B

Market Cap:313.94B

Float Cap:277.82B

Loading ...

Central China Facility to Upgrade with 38 Million Yuan Investment for New Pharmaceutical Intermediate Line

InnoCare Pharma Returns to Profit in H1

MT Newswires Live

Drug Innovation and Computing Hardware Supply Chains Plunge, ChiNext Index Falls Over 3% | 3A Daily Report (August 24, 2026)

China's InnoCare Pharma H1 Revenue Surges, Partly on Orelabrutinib Growth

INNOCARE Posts Interim Results with Profit Turnaround on Adjusted Basis

AH Share Premium Rankings: Market Close Update for August 24

Hong Kong Biotech ETF Offers Full-Chain Access as Drug Developers and CXO Partners Enter Harvest Season

Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion

Ascletis Pharma Slips on Expecting Deeper H1 Loss on R&D Expenses

HBM Holdings to Join Hang Seng Composite Index

MT Newswires Live

PEIJIA-B Surges Over 8% in Morning Trade as Half-Year Results Signal Multiple Positive Catalysts

Press Release: Antengene Announces 2026 Interim Results: Achieves First

Shenyang Cracks Down on Illegal Veterinary Drug Sales: Two Stores Under Investigation

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Dunhuang's Medical Heritage Blends into Tourism, Boosting Wellness Travel Along the Silk Road

mRNA Vaccine Breakthrough: From Prevention to Treatment, a Historic Leap in Oncology

ZYLOXTB Completes Share Buyback Worth Approximately HK$72,200

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Repurchase for Treasury Shares

Weak Dollar and Shifting Tech Narratives: Strategists Favor Resources and Pharma

Citi Raises Keymed Bio Target Price to HK$97.5, Keeps Buy/High Risk Call

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1574/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":491.4579,"timestamp":1788234030106,"preClose":503.39795,"halted":0,"volume":43003878,"delay":0,"changeRate":-0.023719,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-11.940063,"latestTime":"09-01 11:40:31","open":503.51608,"high":505.9005,"low":489.95316,"amount":1572020224,"amplitude":0.031679,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788235200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":3.790203,"peRate":127.340212,"turnoverRate":0.001637,"increases":6,"decrements":24,"flats":2,"marketCap":313940770832,"floatMarketCap":277817033912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":505.9005,"amplitude":0.031679,"preClose":503.39795,"low":489.95316,"pbRate":"3.790203","latestPrice":491.4579,"volume":43003878,"delay":0,"open":503.51608,"prevYearClose":556.26263,"prevWeekClose":523.873,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":512.773,"twentyDayClose":475.248,"sixtyDayClose":459.637,"secType":"PLATE","market":"HK","turnoverRate":0.001637,"peRate":127.340212,"marketCap":313940770832,"floatMarketCap":277817033912,"timestamp":1788234030106,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":24,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1169750351","title":"Central China Facility to Upgrade with 38 Million Yuan Investment for New Pharmaceutical Intermediate Line","url":"https://stock-news.laohu8.com/highlight/detail?id=1169750351","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169750351?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:51","pubTimestamp":1787568675,"startTime":"0","endTime":"0","summary":"A recent environmental assessment disclosure has revealed that Henan Cylaifu Chemical Co., Ltd. is proceeding with a renovation project to produce 200 tonnes of pharmaceutical intermediates annually...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09939","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661227601","title":"InnoCare Pharma Returns to Profit in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2661227601","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661227601?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:50","pubTimestamp":1787565055,"startTime":"0","endTime":"0","summary":"InnoCare Pharma  booked an attributable net profit of 246.4 million yuan in the first half of 2026, returning from a loss of 30.1 million yuan a year ago.Earnings per share stood at 0.14 yuan per share, compared with loss per share of 0.02 yuan per share, according to a Hong Kong bourse disclosure on Monday.The pharmaceutical company's revenue jumped 55.5% to 1.14 billion yuan from 731.4 million yuan a year earlier.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FCA","BK1161","BK0239","BK1574","688428","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149972463","title":"Drug Innovation and Computing Hardware Supply Chains Plunge, ChiNext Index Falls Over 3% | 3A Daily Report (August 24, 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=1149972463","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149972463?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:50","pubTimestamp":1787565027,"startTime":"0","endTime":"0","summary":"The ChiNext Index dropped more than 3% on Tuesday as steep declines in innovative drug development and computing hardware supply chain stocks weighed heavily on market sentiment. 永泰生物-B...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1161","399006","BK1574","06978","159992","399001","07234","MEDX","03147","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661227355","title":"China's InnoCare Pharma H1 Revenue Surges, Partly on Orelabrutinib Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661227355","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661227355?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:44","pubTimestamp":1787564642,"startTime":"0","endTime":"0","summary":"China's InnoCare Pharma H1 revenue surges, partly on orelabrutinib growthOverviewChina biopharmaceutical firm's H1 revenue grew 55.5% yr/yr, driven by drug sales and collaborationsAdjusted net income ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","HK0000306685.HKD","BK1230","BK1161","688428","ZBIO","BK1191","HK0000320264.USD","BK1583","00656","06996","BK4139","BK0239","HK0000306701.USD","HK0000320223.HKD","02696","HK0000165453.HKD","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130729553","title":"INNOCARE Posts Interim Results with Profit Turnaround on Adjusted Basis","url":"https://stock-news.laohu8.com/highlight/detail?id=1130729553","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130729553?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:42","pubTimestamp":1787564541,"startTime":"0","endTime":"0","summary":"INNOCARE (09969) has announced its interim results for 2026, reporting total revenue of approximately RMB 1.137 billion, representing a year-on-year increase of 55.46%. The company achieved an...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969","BK1574","BK0239","BK1161","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163640448","title":"AH Share Premium Rankings: Market Close Update for August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1163640448","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163640448?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:21","pubTimestamp":1787559710,"startTime":"0","endTime":"0","summary":"As of the closing bell on August 24, the latest AH share premium data has been released, highlighting notable divergences between A-share and H-share valuations across dual-listed companies.Leading...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","LU0348816934.USD","03308","EWH","LU0315179316.USD","LU0370786039.SGD","LU0871576103.HKD","01989","BK1166","LU1960683339.HKD","LU0593848301.USD","LU0455707207.USD","LU0314109678.HKD","LU1188198961.HKD","LU2008162690.USD","BK1558","LU2097828557.USD","LU0359201885.HKD","SG9999001226.SGD","LU0348814723.USD","IE00B3M56506.USD","IE0032431581.USD","02846","LU2399975544.HKD","LU0140636845.USD","01349","SG9999001093.SGD","LU0823426480.USD","BK1249","LU0672654166.SGD","LU2125910500.SGD","LU0254981946.USD","LU1769817096.USD","03968","LU0345780521.USD","83188","LU0516423174.USD","LU2294711473.HKD","HK0001040168.HKD","LU0634319403.HKD","LU1813983027.USD","02338","LU2177674079.SGD","BK1614","IE0031814852.USD","LU0488056044.USD","LU0096374516.USD","HK0000352291.HKD","LU0164865239.USD","BK1546","LU2476274720.SGD","HK0000306685.HKD","399300","LU0072913022.USD","LU0326950275.SGD","BK1237","BK1161","LU0862451753.SGD","01057","03200","IE0008369823.USD","SG9999014674.SGD","LU1282648689.USD","LU0737861772.HKD","BK1583","BK1144","LU1105468828.SGD","LU0266512127.USD","LU0791591158.USD","LU0106252389.USD","LU0708995583.HKD","BK1560","LU1211504680.USD","00317","IE0008368742.USD","HK0000352382.USD","LU2097828631.EUR","03759","LU0828237940.HKD","LU1675838814.USD","02827","LU1831875114.USD","01812","LU0828237510.HKD","BK1533","BK1610","LU1226287529.USD","BK1576","LU1282649141.HKD","LU0588546209.SGD","LU0509642566.USD","03143","LU0640798160.USD","LU0531970944.HKD","LU0173614495.USD","03188","LU0211977185.USD","BK1171","BK1507","LU0106959298.USD","LU0456846285.SGD","LU1504937902.USD","LU1808992512.USD","07233","BK1135","IE00BYV24P56.USD","00300","LU0516423091.SGD","IE0034224299.USD","LU0320764599.SGD","01108","LU1008478684.HKD","LU0067412154.USD","LU0348805143.USD","LU0061477393.USD","LU0620787316.HKD","BK1205","BK1186","LU0029875118.USD","LU0572944931.SGD","IE00BVYPNP33.GBP","LU0048580855.USD","HK0000320223.HKD","BK1574","LU0164939612.USD","SG9999006597.SGD","BK1592","LU0348767384.USD","LU0165289439.USD","BK1193","LU1242518857.USD","BK1202","LU0886674414.USD","SG9999004220.SGD","LU0456854461.SGD","SG9999002463.SGD","LU0469268626.HKD","LU0561508036.HKD","LU0231483743.USD","LU1807302812.USD","03750","03130","159982","LU0821914370.USD","HK0000320264.USD","LU0228367735.SGD","BK1607","BK1149","LU0052750758.USD","LU0287142896.SGD","LU0229945570.USD","IE00B0169L03.USD","BK1563","BK1223","SG9999011746.SGD","LU1880383366.USD","LU1244550577.SGD","LU0589944569.HKD","82846","LU0543330566.HKD","LU1244550221.USD","83130","LU0431992006.USD","LU0463099449.HKD","LU1152091754.HKD","BK1198","LU1224709979.USD","LU0149721374.USD","LU2097828805.USD","02899","LU0348827113.USD","LU0543330483.HKD","00668","LU0049853897.USD","00568","LU1720050803.USD","LU3063872942.SGD","LU0417516738.SGD","BK1544","LU0328353924.USD","LU1988902786.USD","00042","03986","LU0540923850.HKD","LU0737861699.HKD","LU1046422090.SGD","LU2778985437.USD","LU1328277881.USD","LU0164880469.USD","BK1190","LU0791590937.USD","06185","LU1366334578.USD","BK1552","LU0828238088.HKD","BK1554","BK1183","00981","LU0348735423.USD","02359","LU0128522157.USD","LU0918141705.HKD","LU2045819591.USD","IE00B031HY20.USD","LU0348825331.USD","LU0039217434.USD","LU0345780281.USD","LU0501845795.SGD","IE00B031J352.USD","IE00BGHQDM52.EUR","LU0823426308.USD","LU0082770016.USD","LU0417516902.SGD","LU1023057109.AUD","HK0001040143.USD","00956","LU0117841782.USD","IE00B5MMRT66.SGD","LU1719994722.HKD","LU0043850808.USD","LU0979878070.USD","LU2476274308.USD","LU0149534421.HKD","LU0918141887.USD","BK1503","IE00BF5LJ272.USD","LU1794554557.SGD","LU2394011477.USD","LU0359201612.USD","LU1251922891.USD","LU0456827905.SGD","LU2097828714.EUR","BK1140","BK1122","LU0329678337.USD","BK1141","LU0228659784.USD","02475","IE00BMCWC346.EUR","HK0000306701.USD","LU0082770016.SGD","LU0327786744.USD","IE00B543WZ88.USD","BK1231","LU2097828474.EUR","LU0516422952.EUR","BK1147","BK1521","LU1880383440.USD","LU0348788117.USD","BK1240","IE00BZ08YT58.USD","00553","LU1366334651.USD","LU1282649067.USD","IE00BVYPNQ40.USD","LU0214875030.USD","LU1115378108.SGD","LU1048596156.SGD","LU0244354667.USD","LU1244550494.USD","LU2264538146.SGD","LU2226246903.HKD","LU0648948544.HKD","LU0516422440.USD","BK1522","IE00BZ08YR35.GBP","03296","02009","BK1564","BK1514","BK1105","LU1064131342.USD","BK1551","LU0348766576.USD","LU2039709279.SGD","LU1770034418.SGD","LU2242644610.SGD","LU1688375341.USD","LU0868486357.SGD","LU1152091168.USD","00895","02768","BK1505","02218","LU0163747925.USD","LU0607220059.USD","LU0531971595.HKD","BK1515","LU0449509016.USD","LU1769817179.HKD","LU0266512473.USD","BK1191","LU0384037296.USD","LU0516422366.SGD","LU0210526637.USD","IE00BZ08YS42.EUR","LU0502904849.HKD","BK1116","LU1303224171.USD","LU0890818403.SGD","LU0880133367.SGD","IE00B29SXG58.USD","02701","BK1594","LU0320764755.SGD","BK1163","BK1526","LU1961090484.USD","LU1481107354.HKD","LU0307460666.USD","BK1214","LU0269904917.USD","01513","LU0797268264.HKD","LU1993786604.SGD","BK1110","LU1242518931.SGD","BK1170","LU0181495838.USD","03328","02691","01081","03678","LU0051755006.USD","LU0359202008.SGD","BK1537","LU0329678170.USD","00187","LU1282649810.SGD","SG9999002828.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184884128","title":"Hong Kong Biotech ETF Offers Full-Chain Access as Drug Developers and CXO Partners Enter Harvest Season","url":"https://stock-news.laohu8.com/highlight/detail?id=1184884128","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184884128?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:10","pubTimestamp":1787559055,"startTime":"0","endTime":"0","summary":"China's innovative drug industry chain is entering a phase where earnings and international expansion are materializing. According to recent interim reports and earnings previews from listed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","LNGR","MEDX","IBBQ","BK1161","CXO","WX","06978","520970","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125046383","title":"Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1125046383","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125046383?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:46","pubTimestamp":1787557589,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) unveiled its half-year financial report in August 2026, and the mid-year scorecard, which had generated considerable market anticipation, fell...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","LU2097828631.EUR","600276","159938","LU0359201885.HKD","LU1820825898.SGD","LU2289578879.USD","LU2328871848.SGD","LU2543165471.USD","LU1781817850.SGD","LU0359202008.SGD","LU1997245177.USD","BK0239","LU1997245094.SGD","09939","LU2488822045.USD","LU2097828805.USD","LU1255011170.USD","BK1574","LU1064131003.USD","LU2097828714.EUR","BK0188","BK0060","LU2148510915.USD","LU0359201612.USD","BK0196","LU1580142542.USD","LU0405327148.USD","BK1161","LU0405327494.USD","LU2097828474.EUR","01276","BK0028","LU1328615791.USD","BK0183","LU2580892789.USD","LU1997244956.HKD","LU2580892862.HKD","LU2097828557.USD","LU1023057109.AUD","LU1655091616.SGD","BK1191","LU1064130708.USD","LU1969619763.USD","LU1146622755.USD","BK1515","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240309","title":"Ascletis Pharma Slips on Expecting Deeper H1 Loss on R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:43","pubTimestamp":1787542991,"startTime":"0","endTime":"0","summary":"BUZZ-Ascletis Pharma slips on expecting deeper H1 loss on R&D expenses** Shares of Ascletis Pharma Inc1672.HKslip 4.5% to HK$9.565, on track for the biggest one-day pct drop since August 10** The viral diseases and oncology focused pharmaceutical products developerexpects to record net lossof 319.7 million yuan  six months ended in June, as compared with a loss of 88 million yuan the same period a year ago** Company said deeper loss is due to significant increase in research and development expenses as it advances its comprehensive metabolic disease pipeline, including both small molecules and peptides** YTD, stock down 15.9%, while Hang Seng Biotech Index.HSBIOup 9.9%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L03A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01672","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661247019","title":"HBM Holdings to Join Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2661247019","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661247019?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:28","pubTimestamp":1787542115,"startTime":"0","endTime":"0","summary":"HBM Holdings (HKG:2142) will be added to the Hang Seng Composite Index from Sept. 7, according to a Monday Hong Kong bourse filing.Its shares are also expected to meet the criteria to be traded through the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DRAL","MUYY","YANG","KWEB","YINN","XPP","DRAM","DRMY","82822","02823","82823","ASHS","DISK","KBA","RAM","02822","DRMP","HSCI","YXI","CHAU","KCAI","HBMX","RAMZ","MUD","82843","MUG","MUU","02843","BK1583","BK1574","FLCH","MUZ","BK4588","BK1161","ASHR","FXP","MIC","MULL","02142","CWEB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171609154","title":"PEIJIA-B Surges Over 8% in Morning Trade as Half-Year Results Signal Multiple Positive Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1171609154","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171609154?lang=en_us&edition=fundamental","pubTime":"2026-08-24 10:48","pubTimestamp":1787539696,"startTime":"0","endTime":"0","summary":"Shares of PEIJIA-B (09996) showed strong momentum during the morning session on August 24, climbing more than 8%. The company recently released its interim results, which highlighted robust key...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","09996","BK1583","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661410992","title":"Press Release: Antengene Announces 2026 Interim Results: Achieves First","url":"https://stock-news.laohu8.com/highlight/detail?id=2661410992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661410992?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:00","pubTimestamp":1787533200,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Aug. 23, 2026 /PRNewswire/ -- Antengene Corporation Limited (\"Antengene\", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","COAL","R","HCC","LU0963586101.USD","06996","BK4588","IE00B19Z4B17.USD","TM","BK1191","03160","BK4022","CRS","IE00B66KJ199.SGD","BK4585","PYZ","BK4187","CR","BK4232","ORR","BK4604","BK4161","BK4555","BK4099","XAR","IE00B7SZL793.SGD","BK1583","IE0031619046.USD","BK1574","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109288534","title":"Shenyang Cracks Down on Illegal Veterinary Drug Sales: Two Stores Under Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=1109288534","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109288534?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:50","pubTimestamp":1787532633,"startTime":"0","endTime":"0","summary":"On August 24, the Agriculture and Rural Affairs Bureau of Yuhong District, Shenyang, issued a public notice regarding a media report from the previous day about veterinary drug stores in the Zhangshi...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241804","title":"Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241804","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241804?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:02","pubTimestamp":1787529767,"startTime":"0","endTime":"0","summary":"Sinopharm interim revenue edges down on softness in pharmaceutical distribution businessOverviewChina pharmaceutical distributor's interim revenue declined slightly year-on-yearNet income attributable","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44K04V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4204","BK1587","LU0640798160.USD","BK1161","HK0000320264.USD","BK1230","01099","BK1500","02696","HK0000306685.HKD","HK0000320223.HKD","BK1515","HK0000306701.USD","BK1197","LU1115378108.SGD","HK0000165453.HKD","EDMCQ","BK1574","00656","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135663784","title":"Dunhuang's Medical Heritage Blends into Tourism, Boosting Wellness Travel Along the Silk Road","url":"https://stock-news.laohu8.com/highlight/detail?id=1135663784","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135663784?lang=en_us&edition=fundamental","pubTime":"2026-08-23 20:51","pubTimestamp":1787489466,"startTime":"0","endTime":"0","summary":"This summer, the rich tapestry of Dunhuang's medical culture—from the \"moxibustion charts\" painted on its ancient grotto walls to the \"prescription collections\" and the legendary \"immortal porridge\"...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09939","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119759096","title":"mRNA Vaccine Breakthrough: From Prevention to Treatment, a Historic Leap in Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1119759096","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119759096?lang=en_us&edition=fundamental","pubTime":"2026-08-23 19:20","pubTimestamp":1787484034,"startTime":"0","endTime":"0","summary":"On August 19, 2026, the pharmaceutical world was set ablaze. US drug giants Moderna and Merck jointly announced the successful Phase III INTerpath-001 clinical trial of their personalized mRNA...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","159938","BK1515","09939","BK1574","BK1161","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134790180","title":"ZYLOXTB Completes Share Buyback Worth Approximately HK$72,200","url":"https://stock-news.laohu8.com/highlight/detail?id=1134790180","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134790180?lang=en_us&edition=fundamental","pubTime":"2026-08-23 18:32","pubTimestamp":1787481162,"startTime":"0","endTime":"0","summary":"On August 21, 2026, ZYLOXTB (02190) announced that it had repurchased 3,500 shares at a cost of approximately HK$72,200. The buyback was executed at a price range of HK$20.6 to HK$20.62 per share.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1100","BK1583","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661824851","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Repurchase for Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661824851","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661824851?lang=en_us&edition=fundamental","pubTime":"2026-08-23 18:20","pubTimestamp":1787480425,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share repurchase for treasury sharesZylox-Tonbridge filed a next-day disclosure return showing 3,500 H shares repurchased on Aug. 21 for treasu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nNDL5xQ3Yr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1100","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119594086","title":"Weak Dollar and Shifting Tech Narratives: Strategists Favor Resources and Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1119594086","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119594086?lang=en_us&edition=fundamental","pubTime":"2026-08-23 16:42","pubTimestamp":1787474551,"startTime":"0","endTime":"0","summary":"Founder Securities has released a research report indicating that the market showed a pattern of initial gains followed by losses this week. After a rapid rebound in the early period, major indices...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","TTTN","BK4588","02834","BK1147","09086","159938","UUP","BK1515","VGT","UDN","09939","07266","07261","07568","BK4585","DBND","XLK","BK1161","03086","03034","09834","03455","07522"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143799433","title":"Citi Raises Keymed Bio Target Price to HK$97.5, Keeps Buy/High Risk Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1143799433","media":"Deep News","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143799433?lang=en_us&edition=fundamental","pubTime":"2026-08-23 12:50","pubTimestamp":1787460624,"startTime":"0","endTime":"0","summary":"Citi has released a research report stating that KEYMED BIO-B (02162) posted first-half 2026 revenue of RMB 617 million, up 24% year-on-year. Within that total, sales of stapokibart reached RMB 393...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154935.USD","LU0128525689.USD","LU0130517989.USD","EWH","BK1587","LU0203347892.USD","LU1267930227.SGD","LU2462157665.USD","C","BK4588","LU1074936037.SGD","LU1506573853.SGD","LU2360032135.SGD","LU1366192091.USD","BK1574","IE00BSNM7G36.USD","TFNS","BK4504","LU0477156953.USD","IYF","LU1244550577.SGD","LU0170899867.USD","LU1791807156.HKD","LU2125154778.USD","BK1161","LU0130102774.USD","BK4559","LU0314106906.USD","LU0320765646.SGD","BK4207","LU1668664300.SGD","LU2417539215.USD","BK4534","LU1201861249.SGD","BK4585","FTXO","LU0648001328.SGD","LU1244550494.USD","LU2236285917.USD","LU0052756011.USD","BK4566","LU0980610538.SGD","LU0203345920.USD","LU0106831901.USD","LU0072461881.USD","BK1583","LU0098860793.USD","LU1244550221.USD","LU2456880835.USD","LU0310800965.SGD","LU1144417596.USD","LU0162691827.USD","LU1162221912.USD","02162"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":12,"totalSize":384,"code":"91000000","status":"200"}]}}